At a glance
- Originator Kaneka
- Class Cytostatic antibiotics
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 27 Jul 1998 Profile reviewed
- 14 Dec 1994 Preclinical development for Cancer in Japan (Unknown route)